Form 4: Tyra Biosciences CFO Alan Fuhrman Acquires Shares Under Employee Stock Purchase Plan
SEC Form 4 Filing
Alan Fuhrman, CFO of Tyra Biosciences, acquired 1,238 shares of common stock under the company's 2021 Employee Stock Purchase Plan at a price of $9.775 per share.
Summary
- On March 14, 2025, Alan Fuhrman, the Chief Financial Officer of Tyra Biosciences, Inc., acquired 1,238 shares of common stock.
- The shares were purchased under the Issuer's 2021 Employee Stock Purchase Plan.
- The price per share was $9.775.
- Following the transaction, Fuhrman directly owns 14,087 shares of Tyra Biosciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a routine transaction under an employee stock purchase plan, indicating confidence but not necessarily a major shift in the company's outlook.
Positives
- The CFO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Employee stock purchase plans are a common way for companies to incentivize employees and align their interests with those of shareholders. This transaction reflects the CFO's participation in such a plan.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of transaction: Alan Fuhrman acquired shares of common stock. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.